Delgen Biosciences Inc.

Chapel Hill, NC

UEI
JMZNRVFEGHC3
CAGE
8TJD0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Asian-Pacific American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov
SAM.gov registration date
Physical address
408 Ironwoods Dr, Chapel Hill, NC 27516, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel polymer-antibody conjugates as long-acting therapeutics for ocular diseases R43EY034044 National Eye Institute (NIH) $700,150

Quick answers

Is Delgen Biosciences Inc. registered in SAM.gov?

Yes. Delgen Biosciences Inc.'s SAM.gov registration is active through May 8, 2027.

What is Delgen Biosciences Inc.'s most recent federal award?

Delgen Biosciences Inc.'s most recent federal grant award is Novel polymer-antibody conjugates as long-acting therapeutics for ocular diseases (R43EY034044), from National Eye Institute (NIH), on September 1, 2023.

On GovTribe

See Delgen Biosciences Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login